Although KIT inhibitors present good inhibitory effects against MCs in vitro, treatment with KIT inhibitors alone has been disappointing in most published clinical trials for mastocytosis [1,4,9], likely due to the development of resistance against kinase inhibitors. The gene discussed is KIT; the disease is mastocytosis.